Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
Antibody therapeutics for inflammatory and autoimmune disease
MabGalaxy develops antibody therapeutics for inflammatory and autoimmune diseases, with scientific operations linked to Cambridge's Babraham Research Campus. Its discovery approach combines immune-system biology with artificial intelligence to support antibody design and selection. The company aims to shorten the…
Human iPSC-derived disease models and drug discovery services
Axol Bioscience is a biotechnology company supplying human induced pluripotent stem cell-derived cells and research services for disease modelling and drug discovery. Its portfolio includes neurons, cardiomyocytes, retinal organoids, retinal pigment epithelium and skin cell models, alongside culture media and custom…
AI-assisted imaging software for minimally invasive vascular surgery
Cydar Medical is a medical software company developing AI-assisted imaging tools for minimally invasive vascular surgery. Its cloud-based platform creates three-dimensional anatomical maps from CT scans and overlays them on live X-ray images to support procedural planning and intraoperative navigation. The software…
Yeast-based production platform for veterinary antibody therapeutics
HERlab develops microbial production systems for animal therapeutics using synthetic biology. Its platform applies AI-driven selection across more than a thousand yeast species to match therapeutic proteins with suitable production hosts. It also develops purification technology with veterinary manufacturing costs in…
AI-enabled biologics discovery and therapeutic development
Divergence Labs develops new medicines by combining molecular engineering, machine learning and high-throughput biological experimentation. Its Cambridge research team integrates antibody and biologics discovery, cell engineering and automated screening to identify and optimise therapeutic candidates. Proprietary…
Complex molecule synthesis and chemistry-driven cancer drug discovery
New Path Molecular Research is a Cambridge-based chemistry company spun out from the laboratory of Professor Steve Ley at the University of Cambridge. The company specialises in the synthesis of complex functional molecules, including natural products, macrocycles and peptides, using flow chemistry and…
Molecular assay platform for genomic profiling in cancer diagnostics
Biofidelity is a Cambridge-based genomic technology company developing molecular assays for cancer biomarker detection in tissue and liquid biopsy samples. Its proprietary platform enables ultra-sensitive detection of somatic mutations at low variant allele fractions using a simplified four-step qPCR workflow, without…
Rapid blood biomarker test for pre-hospital stroke triage
Upfront Diagnostics is a diagnostic biotechnology company developing rapid blood tests for emergency stroke triage. Its lateral-flow assay measures D-dimer and glial fibrillary acidic protein (GFAP) from a finger-prick sample, providing results in under ten minutes to support identification of suspected…
Non-invasive vaginal sampling for gynaecological disease
Ellele Health is a medical research company developing a minimally invasive vaginal sampling device and associated downstream assays for the detection and management of gynaecological conditions. Using a proprietary biospecimen collected from the vaginal wall, the company applies genetic, epigenomic, and microbial…
GMP-grade cell-free synthetic DNA for genetic medicines
4basebio is a biotechnology manufacturing company producing GMP-grade synthetic DNA for use in cell and gene therapies, mRNA vaccines and genome editing applications. Using an enzymatic, cell-free synthesis process, the company manufactures application-specific linear DNA constructs that overcome the purity and…
Human ovarian cell models and multi-omics drug discovery
OvartiX is a Cambridge biotechnology company developing drug-discovery tools and therapeutic programmes for ovarian and reproductive health. Its platform combines human multi-omics datasets, machine learning and engineered two- and three-dimensional ovarian cell models to identify and validate disease targets. Founded…
Single-cell somatic mutation analysis for measuring biological ageing
AgeCurve is a geroscience company developing diagnostics that measure biological ageing at the level of individual cells. Its approach analyses the burden and lineage structure of somatic mutations in single cells, combining genotype with cellular phenotype data through machine learning to estimate how far ageing has…
In silico software and AI for small molecule drug discovery
Optibrium is a software company providing integrated computational platforms for small molecule design, optimisation and data analysis across preclinical drug discovery. Its tools support compound property prediction, multi-parameter optimisation, AI-driven data analysis, de novo design, and structure-based modelling,…
Nanoparticle platform for targeted genetic medicine delivery
ViaNautis is a nanomedicine company developing a polymer nanoparticle platform for the targeted intracellular delivery of genetic therapeutic payloads across difficult-to-penetrate biological barriers. The platform is designed to encapsulate a broad range of genetic cargoes and guide them to specific tissues and cell…
Bispecific antibody platform for cancer immunotherapies
F-star Therapeutics is a clinical-stage biotechnology company developing tetravalent bispecific antibodies for cancer and other serious diseases. Its proprietary platform creates antibodies with four binding sites that simultaneously target two different antigens, enabling focused immune activation in the tumour…
Research collaboration and seed funding for engineering biology
Engineering Biology Interdisciplinary Research Centre is a University of Cambridge initiative supporting research and collaboration in synthetic and engineering biology. It connects academic groups, students and industrial partners across molecular engineering, biomaterials, instrumentation and responsible…
Cheminformatics software for chemical search and drug discovery
NextMove Software is a scientific software company developing cheminformatics tools for pharmaceutical, chemical and biotechnology research. Its applications search molecular structures, extract chemical names and reactions from patents, and analyse electronic laboratory notebook records. The company also supplies…
Rapid molecular tests for industrial and bioprocess contamination
Fuse Diagnostics develops rapid, low-cost molecular tests for use at the point of need. Its disposable tests use proprietary amplification chemistry to detect pathogens and contaminants in under ten minutes, without requiring specialist laboratory infrastructure. The company targets applications in bioprocessing, cell…
Pre-competitive biologics drug discovery platforms and services for partners
Alloy Therapeutics UK is the Cambridge-based research operation of Alloy Therapeutics, a biotechnology platform company providing pre-competitive drug discovery technologies and services across antibody, TCR, genetic medicine, cell therapy, peptide, and drug delivery modalities. The company offers both discovery…
OrganoMaps AI and multi-omics modelling for drug discovery
AI VIVO is a Cambridge biotechnology company combining machine learning and multi-omics data to model disease biology and drug responses. Its OrganoMaps approach links molecular measurements with tissue and organ-level physiological networks, supporting analysis of therapeutic targets and mechanisms of action. The…